Firm news

John Serio was recently interviewed by Bloomberg and Reuters to discuss the appointment of newly confirmed FDA Chief Dr. Robert Califf

16 February 2022 | Applicable law: US

Withers partner John Serio was featured by Bloomberg in their article, “Biden’s FDA Chief Confirmed by Senate With Republicans’ Help” and by Reuters in their article “U.S. Senate Narrowly Confirms Dr. Robert Califf To Lead FDA For Second Time” where John discusses new FDA Chief Dr. Robert Califf.

John shares with Bloomberg that “despite some concerns over Califf’s ties to the pharmaceutical industry, the challenges that the agency continues to face in light of the pandemic calls for an experienced leader that understands the difficulties involved in drug development”. He added that Califf “has worked for decades conducting and overseeing clinical trials and having been the former head of the FDA, he has unique understanding of what is needed to help move promising therapies towards approval.

In his interview with Reuters, John discusses the unique experience Califf brings to the role. “You have somebody now heading the agency that understands the drug discovery process in great detail and understands it not only from an industry standpoint, but also from the agency standpoint.

Read the full Bloomberg Law article here.

Read the full Reuters News article here.

This document (and any information accessed through links in this document) is provided for information purposes only and does not constitute legal advice. Professional legal advice should be obtained before taking or refraining from any action as a result of the contents of this document.


Related experience

As a full-service law firm, we are able to provide advice and information about a wide range of other issues. Here are some related areas.

Join the club

We have lots more news and information that you'll find informative and useful. Let us know what you're interested in and we'll keep you up to date on the issues that matter to you.